ERVW-1 and amyotrophic lateral sclerosis: In an attempt to characterize antibody responses to the HERV-K (HML-2) Env protein it was found that antibody levels to the epitope HERV-K (HML-2) Env-SU 19–37 significantly correlated with clinical measures of disease severity in individuals with ALS [62].